Literature DB >> 2411255

Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs.

K C Preuss, H L Brooks, G J Gross, D C Warltier.   

Abstract

The hemodynamic effects of the dihydropyridine derivative Bay k 8644, a new calcium agonist with positive inotropic actions, were studied in instrumented conscious dogs before and after beta adrenergic blockade with propranolol. Intravenous Bay k 8644 (2, 4, 8 and 20 micrograms/kg/min) produced dose-related increases in arterial and left ventricular systolic pressures and myocardial contractility (+dP/dt; % segment shortening). Coronary blood flow velocity was increased at higher doses. Prior administration of propranolol produced no significant alteration of the hemodynamic effects of Bay k 8644. Increases in arterial and left ventricular pressures produced by Bay k 8644 were controlled by intravenous infusion of sodium nitroprusside with resulting enhancement of positive inotropic effects. The results demonstrate that the hemodynamic responses to this novel calcium agonist with positive inotropic properties are not mediated via beta adrenergic mechanisms and control of increases in arterial pressure lead to enhanced regional contractility.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411255     DOI: 10.1007/bf01907908

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  8 in total

1.  Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.

Authors:  R A Janis; D Rampe; J G Sarmiento; D J Triggle
Journal:  Biochem Biophys Res Commun       Date:  1984-05-31       Impact factor: 3.575

2.  New Ca2+ agonist (Bay K 8644) enhances and induces cardiac slow action potentials.

Authors:  G M Wahler; N Sperelakis
Journal:  Am J Physiol       Date:  1984-08

3.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

4.  A microcomputer-based package for determination of regional and global cardiac function and coronary hemodynamics.

Authors:  D M Wilkison; K C Preuss; D C Warltier
Journal:  J Pharmacol Methods       Date:  1984-08

Review 5.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.

Authors:  P H Stone; E M Antman; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

6.  Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog.

Authors:  P Theroux; D Franklin; J Ross; W S Kemper
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

7.  Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Arzneimittelforschung       Date:  1983

8.  Cardiovascular effects of the nifedipine analog, CGP 28 392, in the conscious dog.

Authors:  K C Preuss; N L Cheung; H L Brooks; D C Warltier
Journal:  J Cardiovasc Pharmacol       Date:  1984 Sep-Oct       Impact factor: 3.105

  8 in total
  3 in total

1.  Pressor responses induced by Bay K 8644 involve both release of adrenal catecholamines and calcium channel activation.

Authors:  S Moreland; M P Ushay; S D Kimball; J R Powell; R S Moreland
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

2.  Ca-agonists: a new class of inotropic drugs.

Authors:  M Bechem; R Gross; S Hebisch; M Schramm
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

3.  Modulation of calcium channel currents in guinea-pig single ventricular heart cells by the dihydropyridine Bay K 8644.

Authors:  F Markwardt; B Nilius
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.